Lifebrain invited to the EC workshop on schizophrenia and other mental disorders

Klaus P. Ebmeier, WP3 leader in Lifebrain (University of Oxford) presented at the workshop on Schizophrenia and other mental disorders organised by the European Commission, 15-16th June, 2017 in Pisa.  

Klaus P.Ebmeier, WP 3 leader in Lifebrain, University of Oxford

The workshop was to showcase the latest developments in EU-funded research in the field of brain imaging tools for mental disorders and to explore the research and innovation challenges to be addressed for advancing the field.

The Workshop brought together the investigators involved in collaborative research projects funded by the EU through the Seventh Framework Programme (call HEALTH.2013.2.2.1-2: Development of effective imaging tools for diagnosis, monitoring and management of mental disorders) and the "Innovative Medicines Initiative".

EU-funded projects exploring neurodegenerative diseases, such as Lifebrain were also be represented to provide a broader view on the state-of-play of brain imaging tools for brain disorders.

Participants presented their results and explored how to coordinate their efforts and capitalise on their results.

The Workshop was organised in collaboration with the European Commission Directorate General for Research and Innovation and the EU Joint Undertaking Initiative "Innovative Medicines Initiative" and was under the patronage of the European Psychiatric Association.

                                                                 WSMD 2017 poster

The participants were lucky enough to enjoy Pisa at candle light, at the Luminara festival (the eve of the patron saint's day).

                                                             The Luminara, Pisa in "candle" light

The presentation of Klaus Ebmeier on Lifebrain and some findings of the Whitehall II study can be downloaded here (pdf).

Published June 20, 2017 11:44 AM - Last modified June 20, 2017 3:58 PM